By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tokai Pharmaceuticals 



Boston  Massachusetts    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Tokai Pharmaceuticals Presents New Clinical Data For Galeterone Among Patients With Advanced Prostate Cancer At American Society of Clinical Oncology 2014 6/2/2014 10:49:18 AM
Updated Phase 2 Clinical Data On Tokai Pharmaceuticals’ Galeterone In Advanced Prostate Cancer To Be Presented At The 2014 American Society of Clinical Oncology Annual Meeting 5/16/2014 8:03:09 AM
Tokai Pharmaceuticals Appoints Khalid Mamlouk, Pharm.D. As Vice President, Head Of Medical Affairs 5/6/2014 8:01:07 AM
Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. As Head Of R&D And Chief Medical Officer 4/15/2014 6:47:45 AM
Tokai Pharmaceuticals To Present At The 34th Annual Cowen and Company Health Care Conference 2/24/2014 6:47:12 AM
Tokai Pharmaceuticals Appoints John McBride As Chief Operating Officer 2/11/2014 8:11:24 AM
Tokai Pharmaceuticals To Present At The Leerink Swann and Company Healthcare Conference 2/5/2014 8:38:58 AM
Tokai Pharmaceuticals To Present At The Leerink Swann and Company Global Healthcare Conference 2/5/2014 7:57:04 AM
New Phase 2 Clinical Data On Tokai Pharmaceuticals’ Galeterone In Advanced Prostate Cancer To Be Presented At 2014 American Society of Clinical Oncology GU Symposium 1/9/2014 7:23:47 AM
Tokai Pharmaceuticals Announces New Preclinical Data Demonstrating Galeterone Suppresses Resistant Prostate Cancer Growth 10/22/2013 10:55:52 AM
123
//-->